WHAT IS KNOWN ALREADY: Vitamin D deficiency has been associated with an increased risk of abnormal pregnancy implantation as well as obstetric complications such as pre-eclampsia and fetal growth restriction. However, the effect of vitamin D on conception and early pregnancy outcomes in couples undergoing ART is poorly understood. 
Introduction
Infertility causes great psychological and sometimes physical distress to one in seven couples (National Institute for Health and Care Excellence, 2013) . In the UK, in 2014, 52 288 women underwent 67 708 IVF treatment cycles (Human Fertility Embryology Authority, 2016) . The overall success rate of these ART was 36.3% (Human Fertility Embryology Authority, 2016) . Since the availability of ART treatment has become more widespread, success rates have gradually increased (Grady et al., 2012) . This has largely been due to the research conducted in embryology, which has enhanced our abilities to select and transfer the embryo with the highest pregnancy potential. More recently, the rate of improvement in success rates has slowed (Busso et al., 2006) . There remains ample room for improvement in fertility treatments to maximize the chances of achieving pregnancy. Much of this lies in improving the likelihood for implantation of the selected embryo that is transferred in to the uterus (Macklon et al., 2002) .
There has been recent interest in the role of vitamin D in reproductive physiology as findings have shown that as much as 20-52% of women of reproductive age are deficient in vitamin D (Tangpricha et al., 2002; Gordon et al., 2004; Sullivan et al., 2005) . It is postulated that vitamin D is important in the process of pregnancy implantation as vitamin D enzymes and receptors have been found in the endometrium (Lerchbaum & Rabe, 2014) . Additionally, vitamin D deficiency has been found to cause decreased fertility capacity, hypogonadism and uterine hypoplasia in animal studies (Halloran & DeLuca, 1980; Kinuta et al., 2000; Yoshizawa et al., 1997; Panda et al., 2001) . In humans, the importance of vitamin D in placental function is the most studied aspect of vitamin D in reproduction (Aghajafari et al., 2013) . Specifically, vitamin D deficiency has been linked to poor placentation, leading to hypertensive disorders of pregnancy (pre-eclampsia and pregnancy induced hypertension) and fetal growth restriction (Aghajafari et al., 2013) . More recently, it has been proposed that vitamin D may be a regulator of initial embryo implantation and that improper implantation, due to vitamin D deficiency, is the cause of poor placentation (Bodnar et al., 2007; Baker et al., 2010; Robinson et al., 2011) .
Our main source of vitamin D, a fat-soluble steroid hormone, is from sunlight. Only a small amount is obtained from our diet. The majority of the body's vitamin D is in the form of vitamin D3 (cholecalciferol), which is photo-chemically synthesized in the skin (Holick, 2007) .
Vitamin D concentrations are usually measured by assay of serum 25-hydroxy vitamin D 3 status. Experts in nutrition have suggested that people are at risk of the detrimental effects of vitamin D deficiency at serum 25-hydroxy vitamin D 3 concentrations of <50 nmol/l (<20 ng/ ml). A concentration of 50-75 nmol/l (21-29 ng/ml) is considered insufficient and greater than 75 nmol/l (greater than 30 ng/ml) is considered vitamin D replete. These vitamin D concentration cut-offs are those adopted by the Endocrine Society (Holick et al., 2011) . Differing vitamin D concentration cut-offs have also been proposed by the Institute of Medicine (IOM), who suggest that vitamin D deficiency is when serum 25-hydroxy vitamin D 3 concentrations are <30 nmol/l (<12 ng/ml), vitamin D insufficency is when serum 25-hydroxy vitamin D 3 concentrations are between 30 and 50 nmol/l (between 12 and 20 ng/ml), and that serum 25-hydroxy vitamin D 3 concentrations greater than 50 nmol/l (greater than 20 ng/ml) are considered replete (Ross et al., 2011) . There is an agreement that serum concentrations greater than 374 nmol/l (greater than 150 ng/ml) are associated with toxicity and adverse effects (Tangpricha et al., 2002; Heaney, 2008; Stephanou et al., 1994; Daftary & Taylor, 2006) .
The biological plausibility that vitamin D plays an important role in implantation has led research groups to investigate the importance of vitamin D in patients undergoing ART. Some studies have found that replete concentrations of vitamin D lead to an increase in clinical pregnancy and live birth rates (Rudick et al., 2012 (Rudick et al., , 2014 Ozkan et al., 2010; Garbedian et al., 2013; Paffoni et al., 2014) . However, others have found conflicting evidence suggesting that vitamin D has no effect on the outcome of ART (Anifandis et al., 2010; Aleyasin et al., 2011; Firouzabadi et al., 2014; Fabris et al., 2014; Franasiak et al., 2015) . The aim of our review was to investigate the association between vitamin D status and reproductive outcomes by meta-analysis of the ART outcomes of published cohort studies to summarize the available evidence.
Materials and Methods

Inclusion criteria
The study was designed a priori with inclusion of primary articles that studied women undergoing any form of ART (IVF, ICSI and frozen embryo transfer [FET] ) who had their vitamin D status checked. This could either be through blood serum or follicular fluid assay. The primary outcome was live birth rates according to vitamin D status. Secondary outcomes included biochemical pregnancy rates, and clinical pregnancy rates.
Literature search
MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and CINAHL (from inception to April 2017) were searched. The search strategy used the following key words and/or medical subject heading (MeSH) terms: pregnancy, IVF, intracytoplasmic sperm injection, ART and vitamin D. The full electronic search strategy is provided in Supplementary Table SI. References of all included primary and review articles were examined to identify relevant articles not captured by the electronic searches. No language restrictions were applied in any of the searches or study selection.
Study selection
Criteria for inclusion in the study were established prior to the literature search. Two independent reviewers (J.C. and B.T.) carried out study selection. First, the independent reviewers scrutinized the titles and abstracts of the electronic searches. Each title and abstract were included or excluded independently according to the predefined inclusion criteria; any disagreements regarding inclusion were resolved by a further reviewer (I.D.G). The full manuscripts of the titles and abstracts considered to be relevant for inclusion were obtained. When there was a duplicate publication, the most recent and complete version was selected and included. Studies that did not explicitly report results from ARTs according to vitamin D groups (deficient, insufficient and replete) according to Endocrine Society guidelines were excluded.
The same two independent reviewers (J.C. and B.T.) extracted the outcome data from the included studies.
Study quality assessment
Two reviewers (J.C and B.T.) used the Newcastle-Ottawa Quality Assessment Scales for observational studies to complete a quality assessment of the included manuscripts (Wells et al., 2011) . The NewcastleOttawa scale ranges from zero to nine, awarding one star for all categories (case-cohort representative, ascertainment of exposure, outcome negative at commencement of study, outcome assessment, duration of followup and adequacy of follow-up) except comparability by design or analysis where two stars can be awarded. An arbitrary score was allocated assuming that all items have equal weighting. This was used to give a quantitative appraisal of overall quality of the individual studies. Each study received a score from each of the reviewers.
Publication bias
Assessment for publication bias in the included studies for the outcome of clinical pregnancy was performed using Harbord's modified test for small study effects to assess for funnel plot asymmetry (Harbord et al., 2006) .
Statistical analysis
Live birth, biochemical pregnancy, clinical pregnancy and miscarriage rates were extracted from each of the included studies according to vitamin D strata. The log of the ratio and its corresponding standard error for each study was computed. Meta-analysis using inverse-variance weighting was performed to calculate the random-effects summary estimates. The square root of this number is the estimated standard deviation of the underlying effects across studies. Because, we had relative measures of effect, the CIs were centered on the natural logarithm of the pooled estimate and the limits exponentiated to obtain an interval on the ratio scale. Forest plots were created for each outcome, showing individual study proportions with CIs and the overall DerSimmonian-Laird pooled estimate according to vitamin D status. Heterogeneity of the treatment effects was assessed graphically with forest plots and statistically analyzed using the χ 2 test. Statistical analyses were performed using Stata 12.1 (StataCorp, College Station, TX, USA).
Results
The PRISMA flow diagram Moher et al., 2009) of the review process is presented in Fig. 1 . The search strategy yielded 4615 citations, of which 4505 citations were excluded as it was clear from scrutinizing the title and abstract that they did not fulfill the selection criteria. Full manuscripts of 110 articles were obtained. A total of 99 of these publications were excluded because 35 were reviews, 24 articles did not specify outcomes from ART, 17 articles did not specify investigating vitamin D, seven articles were conference abstracts or studies where there was no extractable data (Farzadi et al., 2015; Neville et al., 2016 ) (as they provided mean vitamin D concentrations of groups of women achieving clinical pregnancy and those that did not), five articles reported male infertility, four articles were animal studies, three were letters, two were duplicates, and one was a study protocol. Therefore, the total number of observational studies included in the review was 11.
Study characteristics
Study characteristics of the 11 included studies are presented in Table I . None of the included studies declared any conflicts of interest. The included studies varied in publication date between 2010 and 2015. All 11 included studies were cohort studies; 6 were retrospective and 5 were prospective in design. Sample sizes varied between 84 women to 517 women. Nine of the 11 included studies reported the ages of their study population. Seven studies had a mean age of below 37 years and two had a higher mean age of 40.5 and 40.9 years. Eight included studies used serum measurement of vitamin D, two used both follicular fluid and serum vitamin D (finding that there was high correlation between the follicular fluid vitamin D and serum vitamin D in their participants), and one study used follicular fluid alone. Of the 11 included studies, nine studies reported ART where women had used autologous oocytes. Two reported results from women who were donor egg recipients. One study used pre-implantation genetic screening to ensure that patients had karyotypically normal embryos transferred. One study chose to only study women that underwent a single blastocyst transfer. All of the 11 included studies assayed 25-hydroxy-vitamin D. Four of the included studies assessed vitamin D before the commencement of the treatment cycle, three assessed vitamin D at the time of ovulation trigger, three assessed vitamin D at the time of oocyte retrieval, and one study assessed vitamin D just before oocyte retrieval. All of the 11 included studies used the Endocrine Society classification of vitamin D status (<50 nmol/l deficient, 50-75 nmol/l insufficient and greater than 75nmol/l replete). Six of the included studies provided adjusted odds ratios, adjusting for potential confounding factors. Of these six studies, only four provided adequate detail for potential meta-analysis of adjusted odds ratios. However, two of these studies had adjusted for vitamin D concentration and another two studies had used differing referent groups to obtain adjusted odds ratios. A funnel plot to test for asymmetry did not find substantial evidence of publication bias (P = 0.933) ( Supplementary Fig. S1 ).
All studies scored well using the Newcastle-Ottawa Quality Assessment achieving a score between 7 and 9 (Table II) .
Vitamin D deficiency prevalence
Our review found a high prevalence of vitamin D deficiency. The meta-analyzed prevalence for vitamin D deficiency, insufficiency and replete were 34.6% (95% CI 32.0-37.4), 45.3% (95% CI 42.4-48.5) and 25.7% (95% CI 23.4-28.2%), respectively.
Live birth
Seven studies (2026 participants) reported the live births achieved by women when categorized by vitamin D (Fig. 2) . Meta-analysis of the data from these studies showed that women who are vitamin D replete have a higher chance of achieving a live birth from ART when compared with women with vitamin D deficiency or insufficiency. The odds ratio was 1.33 (1.08-1.65). The meta-analysis had low statistical heterogeneity with an I 2 value of 5.0% (P = 0.39).
Biochemical pregnancy
Five studies (1700 participants) reported the number of women that achieved a positive pregnancy test approximately two weeks after embryo transfer for the three vitamin D categories. The odds of biochemical pregnancy in the vitamin D deficient and insufficient population versus the vitamin D replete population are presented in Fig. 3 . Meta-analysis of these five cohort studies showed a greater chance of pregnancy in the vitamin D replete group when compared with the vitamin D deficient and insufficient groups with an odds ratio of 1.34 (1.04-1.73). There was a low level of statistical heterogeneity with an I 2 value of 21.0% (P = 0.28).
Clinical pregnancy
All 11 studies (2700 participants) reported on clinical pregnancy rate (the presence of fetal heart approximately five weeks after embryo transfer) as an outcome (Fig. 4) . Pooling of the clinical pregnancy outcomes from the 11 studies showed an improved chance of clinical pregnancy in the vitamin D replete population when compared with the vitamin D deficient and insufficient population. The vitamin D replete group was more likely to achieve clinical pregnancy when compared with the vitamin D deficient and insufficient groups with an odds ratio of 1.46 (1.05-2.02). The I 2 value for this meta-analysis was 61.0%
suggesting a moderate level of statistical heterogeneity (P = 0.02). Data could be extracted from nine of the included studies (2082 patients) to compare the chances of clinical pregnancy by using the IOM definitions of vitamin D status (vitamin D concentrations of <50 nmol/l considered as deficient or insufficient and vitamin D concentrations of more than 50 nmol/l considered replete). Pooling of the clinical pregnancy rates from these nine studies also showed that women with a vitamin D concentration of greater than 50 nmol/l were more likely to achieve a clinical pregnancy when compared to women with a vitamin D concentration of below 50 nmol/l with an odds ratio of 1.38 (1.04-1.83) ( Supplementary Fig. S2 ).
Clinical pregnancy according to source of oocyte used
The 11 included studies were divided into two groups according to the source of the oocyte (autologous or donor) used to form the embryo Total number of citations retrieved from electronic searches; n = 4615 Citations excluded after screening title and abstract; n = 4505
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Articles included for systematic review; n = 11 Rudick et al. In the two studies (including 366 patients) where women received a donor oocyte embryo, no significant difference was found when comparing the clinical pregnancy in women receiving a donor oocyte embryo who were vitamin D replete when compared to women who were vitamin D deficient or insufficient .26]). The I 2 value for this meta-analysis was 85.0% suggesting a considerable level of statistical heterogeneity (P = 0.009).
Miscarriage
Six studies (1635 participants) reported on the outcome of miscarriage (Fig. 6) . When the data from these six studies are pooled, the chance of miscarriage in the vitamin D replete women is similar to that of vitamin D deficient and insufficient women with an odds ratio of 1.12 (0.81-1.54). There was a low level of statistical heterogeneity denoted by an I 2 value of 0.0% (P = 0.76).
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Heterogeneity: Tau Our analysis was strengthened by a number of factors. A comprehensive search strategy was used, employing relevant research databases. Additionally, a valid data synthesis method was implemented and no language restrictions were applied. The Newcastle-Ottawa Quality Assessment Scale was used to assess the quality of the included studies. The assessment of all studies scored well on this scale, suggesting low risk of bias.
There are also weaknesses in our analysis, which mainly stem from the clinical heterogeneity of the publications that were included. Some degree of heterogeneity is to be expected due to the different geographical locations that the individual cohort studies have been conducted, leading to differing population characteristics and ART protocols used. However, this is not necessarily a disadvantage as some degree of clinical heterogeneity can increase the generalizability of the findings to wider infertility populations.
Ideally, when meta-analyzing cohort studies, the adjusted odds ratios (where provided) should be meta-analyzed. However, in our included studies it was infrequent for the included primary studies to have provided sufficient detail of their adjusted analysis for known confounding factors such as age and BMI. Therefore, we were unable to perform a meta-analysis of adjusted odds ratios.
One source of clinical heterogeneity between the included studies is in the timing of vitamin D assessment. Some of the studies measured their participants' vitamin D status before the start of ART, whereas others measured vitamin D at the time of oocyte retrieval. Vitamin D status is known to not fluctuate over time unless vitamin D deficiency or insufficiency is actually treated (Anagnostis et al., 2013) . Therefore, the importance of the difference in timing of the vitamin D assessment reduces.
There were also differences in the bio-fluid used to assess vitamin D status amongst the included studies. Three of the included studies measured vitamin D in the follicular fluid aspirated at the time of oocyte retrieval. The remaining studies used blood serum for vitamin Figure 5 Meta-analysis of studies reporting clinical pregnancy by vitamin D concentrations according to source of oocyte. Meta-analysis of the data from nine included studies showed that women who are vitamin D replete have a higher chance of achieving a clinical pregnancy from ART using autologous oocytes when compared with women with vitamin D deficiency or insufficiency. Meta-analysis of the data from two included studies showed no difference in the chance of clinical pregnancy in women replete, insufficient or deficient in vitamin D undergoing ART using donor oocytes. D measurement. Reassuringly, a number of previously published studies have found that assays of vitamin D in follicular fluid or blood serum produce results that are highly correlative (Aleyasin et al., 2011; Anifandis et al., 2010; Firouzabadi et al., 2014; Ozkan et al., 2010) . Serum vitamin D would be measured more conveniently in women undergoing ART and could be tested before the start of treatment to allow time for correction of deficiency.
We found that the likelihood of achieving a positive pregnancy test after embryo transfer was higher in women who were replete in vitamin D. This would support the hypothesis that vitamin D affects embryo implantation. Two of the included studies have tried to investigate the effect of vitamin D on implantation further by only including women undergoing oocyte recipient treatment cycles (Fabris et al., 2014; Rudick et al., 2014) . Isolating recipients of donor oocyte embryos aims to reduce the impact of oocyte quality on reproductive outcomes. Donated oocytes would be sourced from younger women with higher quality oocytes and therefore implantation can be investigated more accurately. Meta-analysis of the clinical pregnancy data from these two studies (including 366 patients) did not show a statistically significant difference in chance of clinical pregnancy between the vitamin D replete and vitamin D deficient or insufficient populations. However, the data may suggest a higher chance of clinical pregnancy in the vitamin D replete group. It is likely that the failure to reach statistical significance is due to the low number of participants in view of the wide CIs (Cochrane Collaboration, 2011) . Removal of these two studies from the overall analysis did not alter the overall association between vitamin D concentration and clinical pregnancy.
Seasonal variations in conception rates have been established (Rojansky et al., 1992 ) with higher conception rates found in the Summer and Autumn. Although many hypotheses have been postulated to explain this phenomenon (e.g. reduced ovulation rates and poorer sperm quality in darker months) the exact mechanism behind this has not been explained. It is possible that an increase in sun exposure and greater sunlight luminosity increases the body's store of vitamin D, thereby yielding higher conception rates in Summer and Autumn.
Although, the debate regarding the importance of vitamin D and seasonal variation in reproductive health continues, its impact on immunomodulation within the endometrium with a resultant reduction in active inflammatory cytokines is now well understood (Holick, 2007) . The expression of vitamin D receptors at the level of the endometrium and the role of vitamin D in the transcription of HOX10A gene (found to be of key importance in implantation) suggest that the immunomodulatory effects of vitamin D may have a direct impact on implantation and therefore the likelihood of reproductive treatment success (Evans et al., 2004) .
Ethnicity has also been found to be a prognostic marker for IVF treatment success, with women of Asian and Black ethnic origins having worse reproductive outcomes (Dhillon et al., 2016) . One possible explanation for this finding could be lower serum vitamin D concentrations in these ethnic groups or differences in the vitamin D receptor gene polymorphisms (Ingles, 2007; John et al., 2007) .
Our review demonstrates that replete vitamin D status is associated with greater chances of ART success. This could be via the actions of vitamin D on the endometrium promoting embryo implantation or as a surrogate marker for general well-being (Lerchbaum & Rabe, 2014) . Vitamin D serum testing is relatively cheap and widely available and its treatment is not costly. Therefore, it may be beneficial to diagnose and treat vitamin D deficiency in women planning ART to optimize their pregnancy outcomes. Correction of vitamin D deficiency in these patients would also be of benefit during pregnancy, as replete vitamin D concentrations have been found to reduce the risk of obstetric complications such as gestational diabetes (Wang et al., 2012; Zhang et al., 2015) , pre-eclampsia (Moon et al., 2015; De-Regil et al., 2012; Wei, 2014) and fetal growth restriction (Conde-Agudelo et al., 2013; Khalessi et al., 2015) . To further investigate the value of treatment of vitamin D deficiency in the infertile population an interventional trial would be necessary.
Supplementary data
Supplementary data are available at Human Reproduction online. Figure 6 Meta-analysis of studies reporting miscarriage by vitamin D concentrations. Meta-analysis of the data from six included studies that reported miscarriage as an outcome showed no difference in the chance of miscarriage in women replete, insufficient or deficient in vitamin D undergoing ART.
